# FDA Inspection 1002583 - Biotest Pharmaceuticals Corp. - January 25, 2017

Source: https://www.globalkeysolutions.net/records/fda_inspections/biotest-pharmaceuticals-corp/64efdbff-4fc2-4fc0-a7cf-4c71f795ad15/
Source feed: FDA_Inspections

> FDA Inspection 1002583 for Biotest Pharmaceuticals Corp. on January 25, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1002583
- Company Name: Biotest Pharmaceuticals Corp.
- Inspection Date: 2017-01-25
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1088430 - 2019-04-08](https://www.globalkeysolutions.net/api/records/fda_inspections/biotest-pharmaceuticals-corp/701b9ed0-5422-4bbb-ad6b-a42bd2b2cadc/)
- [FDA Inspection 868614 - 2014-02-07](https://www.globalkeysolutions.net/api/records/fda_inspections/biotest-pharmaceuticals-corp/84505517-a064-44e4-a861-1c76d2b7229d/)

Company: https://www.globalkeysolutions.net/companies/biotest-pharmaceuticals-corp/ae280934-cee9-4e6a-a6fe-53873d1fc302

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d